Abstract
Feiko ter Kuile and colleagues argue that there is an urgent need to develop targeted pharmacovigilance systems to assess the safety of antimalarials in early pregnancy.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
-
Review
MeSH terms
-
Animals
-
Antimalarials / adverse effects*
-
Endemic Diseases* / statistics & numerical data
-
Female
-
Humans
-
Malaria / drug therapy
-
Malaria / epidemiology*
-
Maternal Exposure* / prevention & control
-
Maternal Exposure* / statistics & numerical data
-
Pregnancy
-
Prenatal Exposure Delayed Effects
-
Registries* / statistics & numerical data